on BioRiver E.V.
11th BioRiver Boost: Celebrating Innovation in Biotechnology
The 11th BioRiver Boost competition has announced its winners for 2024. Ingineeon, a Munich-based firm specializing in cytokine-based immunotherapies, secured the first place. Their innovative approach targets cancer, infectious diseases, and autoimmune disorders.
Second place went to Berlin's TCBalance Biopharmaceuticals GmbH, which develops therapies based on regulatory T cells to address chronic diseases. Bonn's Sweethoven Biotech, known for creating a sustainable sweet-tasting fiber, took third place.
A special prize was awarded to TumiKo, an Essen-based start-up, giving them a guaranteed finalist position in next year's competition.
BioRiver Boost, organized by BioRiver e.V., offers crucial support and networking opportunities for young life science companies. The competition was judged by executives from prominent global life science firms and financiers.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BioRiver E.V. news